Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M86.6Revenue (TTM) $M--Net Margin (%)--Altman Z-Score--
Enterprise Value $M2.4EPS (TTM) $-2.6Operating Margin %--Piotroski F-Score--
P/E(ttm)--Beneish M-Score--Pre-tax Margin (%)--Higher ROA y-yN
Price/Book--10-y EBITDA Growth Rate %--Quick Ratio--Cash flow > EarningsN
Price/Sales--5-y EBITDA Growth Rate %--Current Ratio--Lower Leverage y-yN
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)--Higher Current Ratio y-yN
Dividend Yield %--PEG--ROE % (ttm)--Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M23.7ROIC % (ttm)--Gross Margin Increase y-yN

Gurus Latest Trades with LIFE

Number of guru portfolios checked: 68.
Ticker Guru Date Action
Impact Price Range
(Average)*
Current Price Change from Average Comment Current Shares

LIFE is held by these investors:



LIFE: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
SCHIMMEL PAULDirector 2016-12-21Buy25,000$2.2860.09view
Amanullah AshrafVice President, Manufacturing 2016-12-20Buy11,000$2.2562.22view
MENDLEIN JOHNCEO and Director 2016-12-19Buy69,000$2.265.91view
SCHIMMEL PAULDirector 2016-12-16Buy50,000$2.4847.18view
Matsuoka GroveSee Remarks 2016-05-11Buy12,412$3.0420.07view
SCHIMMEL PAULDirector 2016-04-14Buy66,219$4.18-12.68view
SCHIMMEL PAULDirector 2016-04-13Buy9,835$3.85-5.19view
SCHIMMEL PAULDirector 2016-04-12Buy9,127$3.71-1.62view
SCHIMMEL PAULDirector 2016-04-11Buy32,659$3.572.24view
SCHIMMEL PAULDirector 2016-04-11Buy32,659$3.572.24view

Press Releases about LIFE :

Quarterly/Annual Reports about LIFE:

News about LIFE:

Articles On GuruFocus.com

More From Other Websites
Atyr Pharma Stock Spikes 33% on FDA Updates Jan 19 2017
FDA Grants Fast Track Designation for aTyr's Resolaris™ to Treat Limb Girdle Muscular Dystrophy 2B... Jan 18 2017
ATYR PHARMA INC Files SEC form 8-K, Regulation FD Disclosure Jan 09 2017
Roberts recuses from patent case after discovering conflict Jan 04 2017
Roberts recuses from patent case after discovering conflict Jan 04 2017
Atyr Pharma Inc (LIFE) CEO and Director John Mendlein Bought $151,800 of Shares Dec 21 2016
Does aTyr Pharma Inc (LIFE) Stack Up Against Its Peers? Dec 16 2016
aTyr Pharma downgraded by JP Morgan Dec 13 2016
aTyr Pharma Drops on Clinical Update Dec 13 2016
ATYR PHARMA INC Files SEC form 8-K, Regulation FD Disclosure, Other Events Dec 13 2016
aTyr Pharma Reports Promising Signals of Clinical Activity in Multiple Rare Genetically Distinct... Dec 13 2016
aTyr Pharma to Present at the BMO Prescriptions for Success Healthcare Conference Dec 09 2016
aTyr Pharma, Inc. :LIFE-US: Earnings Analysis: Q3, 2016 By the Numbers : December 5, 2016 Dec 05 2016
ATYR PHARMA INC Financials Nov 23 2016
aTyr Pharma Enters into $20 Million Credit Facility Nov 21 2016
ATYR PHARMA INC Files SEC form 8-K, Entry into a Material Definitive Agreement, Termination of a... Nov 21 2016
aTyr Pharma Enters into $20 Million Credit Facility Nov 21 2016
aTyr Pharma (LIFE) Looks Good: Stock Adds 5.9% in Session Nov 18 2016
aTyr Pharma Announces Third Quarter 2016 Operating Results Nov 14 2016
ATYR PHARMA INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Nov 14 2016

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)